PeptideDB

PB2 914940-24-2

PB2 914940-24-2

CAS No.: 914940-24-2

PB2 is a tris(2-carboxyethyl)phosphine (TCEP) analogue that increases the survival of retinal ganglion (RGCs) cells in v
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

PB2 is a tris(2-carboxyethyl)phosphine (TCEP) analogue that increases the survival of retinal ganglion (RGCs) cells in vitro at nanomolar and picomolar concentrations. PB2 is more permeable (penetrable) than TCEP. PB2, as a reducing agent, has a high neuro-protection effect on RGCs.

Physicochemical Properties


Molecular Formula C16H20BO2P
Molecular Weight 286.11
CAS # 914940-24-2
Appearance White to off-white solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro RGC viability is increased by PB2 (0.001~100000 nM; 72 hours; RGCs) [1]. The alterations made to PB2 balance out the compounds' polarity. Cytosolic esterases are expected to break the methylesters of PB2, producing a polar intracellular intermediate that is unlikely to traverse cell membranes[1].
Cell Assay Cell Viability Assay[1]
Cell Types: RGCs
Tested Concentrations: 0.001~100000 nM
Incubation Duration: 72 hrs (hours)
Experimental Results: Increased RGC viability.
References [1]. Schlieve CR, et al. Synthesis and characterization of a novel class of reducing agents that are highly neuroprotective for retinal ganglion cells. Exp Eye Res. 2006;83(5):1252-1259.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (349.52 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (8.74 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (8.74 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (8.74 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.4952 mL 17.4758 mL 34.9516 mL
5 mM 0.6990 mL 3.4952 mL 6.9903 mL
10 mM 0.3495 mL 1.7476 mL 3.4952 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.